| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0135 |
Injection, adalimumab, 20 mg |
616 |
545 |
$408K |
| J3490 |
Unclassified drugs |
520 |
461 |
$196K |
| J3590 |
Unclassified biologics |
165 |
154 |
$119K |
| J2941 |
Injection, somatropin, 1 mg |
55 |
53 |
$15K |
| J1438 |
Injection, etanercept, 25 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) |
91 |
67 |
$5K |
| J1726 |
Injection, hydroxyprogesterone caproate, (makena), 10 mg |
13 |
13 |
$3K |
| 90746 |
|
23 |
23 |
$270.37 |
| 90715 |
|
36 |
34 |
$142.11 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
178 |
156 |
$30.12 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
75 |
69 |
$0.00 |
| J9355 |
Injection, trastuzumab, excludes biosimilar, 10 mg |
48 |
36 |
$0.00 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20 |
19 |
$0.00 |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
46 |
39 |
$0.00 |